Introduction {#S1}
============

In mammals, the ovary is the reproductive organs of females, and its main function is to produce oocytes and steroids. At present, it's believed that follicular development is triggered by follicle-stimulating hormone (FSH) and the following ovulation is induced by luteinizing hormone (LH) surge ([@B19]; [@B14]; [@B26]; [@B35]). Pregnant mare serum gonadotropin (PMSG) can not only trigger the follicular development mainly similar to FSH, but also induce the following ovulation like LH, which was widely used in the field of reproductive investigation ([@B21]; [@B31]; [@B24]; [@B16]). It is worth noting that Espey put forward the hypothesis of ovulation as an inflammatory reaction ([@B11]), but the detailed mechanism regulating ovarian ovulation still remains unknown. Until recently, the researches on the nucleotide leukin rich polypeptide 3 (NLRP3) inflammasome shred light on it ([@B2]; [@B13]; [@B9]; [@B18]; [@B30]; [@B36]).

The inflammasome is the cellular machinery responsible for activation of inflammatory reaction ([@B22]; [@B37]; [@B20]), which includes four types, like NLRP1, NLRP3, IPAF, and AIM2 inflammasome ([@B4]; [@B1]; [@B7]). NLRP3 inflammasome is a proteolytic complex of NLRP3, ASC, and caspase-1, which is well characterized ([@B4]; [@B1]; [@B6]; [@B39]; [@B7]; [@B33]). Upon activation, NLRP3 binds to the ASC, which in turn recruits pro-caspase-1 to form an integrated inflammasome complex ([@B37]; [@B4]; [@B20]; [@B1]; [@B6], [@B7]; [@B39]; [@B33]), and subsequently cleaves pro-caspase-1 into activated caspase-1, leading to the production of matured IL-1β ([@B37]; [@B4]; [@B20]; [@B1]; [@B6]; [@B39]; [@B7]; [@B33]), which is an important inflammatory cytokine ([@B37]; [@B4]; [@B20]; [@B1]; [@B6]; [@B39]; [@B7]; [@B33]). However, the expression and contribution of NLRP3 Inflammasome during follicular development and ovarian ovulation still unknown.

Given the parallels of ovulation with inflammatory processes and the correlation of non-steroidal anti-inflammatory drug use with reversible infertility ([@B3]; [@B23]; [@B10]), the present study therefore utilized animal model to examine that expression and localization of NLRP3 inflammasome through immunohistochemistry and Western blotting during the follicular development induced by PMSG for help to further clarify the ovulatory mechanism in mammals.

Materials and Methods {#S2}
=====================

Experimental Design {#S2.SS1}
-------------------

Immature female C57BL/6 mice (21-day old) were purchased from Wushi Experimental Animal Supply Co. Ltd. (Fuzhou, China) and maintained in the Laboratory Animal Center of Fujian Normal University under a 14-h light/10-h dark schedule with continuous supply of chow and water. The follicular development was induced in the mice treated with 10 IU PMSG (i.p., Sigma-Aldrich, St. Louis, MO, United States) for 0, 24, and 52 h. The left ovary of each animal was fixed in 4% paraformaldehyde for immunohistochemistry, and the right one was snap-frozen for the examination of gene and protein expression levels. The experiment was repeated two times.

Immunohistochemistry {#S2.SS2}
--------------------

After fixation, 5-μm sections were processed for immunohistochemical analysis with anti-NLRP3 antibody (1:500, Abcam, Cambridge, MA, United States), anti-ASC antibody (1:500, Abcam, Cambridge, MA, United States) and anti-IL-1β antibody (1:500, Abcam, Cambridge, MA, United States). The negative control used serum (Boster Biological Technology, Wuhan, China) instead of primary antibody and the immunoreactivity was visualized by the Elite ABC kit (BioGenex, San Ramon, CA, United States). Three independent observers were asked to assess the intensity of immunostaining ([@B28]; [@B15]) and the evaluation of relative staining levels was repeated at least four times ([@B38]).

Western Blot Analysis {#S2.SS3}
---------------------

Cytoplasmic protein extracts were prepared with the Protein Extraction Kit (Beyotime Biotechnology, Shanghai, China) according to the manufacturer's instructions, and the concentrations were determined by a BCA assay kit (Beyotime Biotechnology, Shanghai, China). These proteins were used for the following examination of expression levels and activities. The expression levels of different proteins were analyzed by Western blotting as described previously ([@B40]). NLRP3 antibody (1:1000, Abcam, Cambridge, MA, United States), ASC antibody 1:1000, Abcam, Cambridge, MA, United States), Pro-caspase-1 antibody (1:1000, Abcam, Cambridge, MA, United States), cleaved-caspase-1 antibody (1:1000, Abcam, Cambridge, MA, United States), IL-1β antibody (1:500, Abcam, Cambridge, MA, United States) and β-actin antibody (1:5000, Novus Biologicals, Littleton, CO, United States) were used.

Real Time PCR Analysis {#S2.SS4}
----------------------

Total RNA was extracted using TRIzol (Life Technologies, Carlsbad, CA, United States) and then reverse-transcribed (cDNA Synthesis Kit, Bio-Rad, Hercules, CA, United States). The reverse-transcribed products were amplified using a TaqMan Gene Expression Assay kit (Applied Biosystems, Foster City, CA, United States), including TaqMan Universal PCR Master Mix, hypoxia-inducible factor (HIF)-1α primer (Hs00936372_m1) and endothelin (ET)-1 primer (Mm00438656_m1). The levels of 18S ribosomal RNA (Rn03928990_g1) was used as an endogenous control. The relative gene expressions were calculated with the ΔΔCt method. Relative mRNA levels were expressed as 2^--ΔΔCt^ values.

Caspase-1 Activity and IL-1β Production Assay {#S2.SS5}
---------------------------------------------

The assay of caspase-1 activity was performed by Caspase-1 Colorimetric Assay Kit (Biovision, Milpitas, CA, United States) and the level of IL-1β production was measured by IL-1β ELISA Kit (Bender Medsystems, Burlingame, CA, United States) according to the protocol described by the manufacturer. These data were expressed as the fold change compared with the control.

Statistics {#S2.SS6}
----------

Data are presented as mean ± SE. The significance of differences in mean values within multiple groups was evaluated using a one-way analysis of variance (ANOVA), followed by a Tukey's multiple range test. *P* \< 0.05 was considered statistically significant.

Results {#S3}
=======

Immunohistochemical Analysis of NLRP3 Inflammasomes {#S3.SS1}
---------------------------------------------------

In the present study, the localization of the core protein NLRP3 and the adaptor protein ASC of inflammasomes were examined through immunohistochemical staining ([Figures 1](#F1){ref-type="fig"}, [2](#F2){ref-type="fig"}), and the relative expressions were present in [Tables 1](#T1){ref-type="table"}, [2](#T1){ref-type="table"}. The results showed NLRP3 mainly expressed in the outside of intrafollicular fluid in the ovaries with PMSG-52 h treatment ([Figure 1](#F1){ref-type="fig"}), which was similar with the pattern of ASC expressions ([Figure 2](#F2){ref-type="fig"}).

![NLRP3 immunohistochemistry in the ovary during the follicular development induced by PMSG Ovarian sections were immunostained for NLRP3 and counterstained with hematoxylin. The NLRP3 immunohistochemical signals appear brown, and the background counterstaining appears blue. Negative control remained unstained, lacking primary antibody instead of serum. GC, granulosa cell; Oo, oocyte; bar = 100 μm.](fcell-07-00256-g001){#F1}

![ASC immunohistochemistry in the ovary during the follicular development induced by PMSG Ovarian sections were immunostained for ASC and counterstained with hematoxylin. The ASC immunohistochemical signals appear brown, and the background counterstaining appears blue. Negative control remained unstained, lacking primary antibody instead of serum. GC, granulosa cell; Oo, oocyte; bar = 100 μm.](fcell-07-00256-g002){#F2}

###### 

Relative abundances of NLRP3 in the ovary during follicular development induced by PMSG.

                       **Staining intensity**        
  -------------------- ------------------------ ---- -----
  Oocyte                                             
   Primordial          −                        NA   NA
   Primary             −                        −    \+
   Secondary           −                        \+   \+
   Tertiary            NA                       NA   \+
  Granulosa cells                                    
   Primordial          −                        NA   NA
   Primary             −                        −    −
   Secondary           −                        −    −
   Tertiary            NA                       NA   −
  Theca cells                                        
   Secondary           \+                       \+   \+
   Tertiary            NA                       NA   \+
   Endothelial cells   \+                       \+   ++
  Follicular fluid     −                        −    +++

−, no staining detected; +, weak; ++, moderate; +++, strong; NA, not available.

###### 

Relative abundances of ASC in the ovary during follicular development induced by PMSG.

  **Follicular development**   **Staining intensity**        
  ---------------------------- ------------------------ ---- -----
  Oocyte                                                     
   Primordial                  −                        NA   NA
   Primary                     −                        −    \+
   Secondary                   \+                       ++   ++
   Tertiary                    NA                       NA   ++
  Granulosa cells                                            
   Primordial                  −                        NA   NA
   Primary                     −                        −    −
   Secondary                   −                        −    −
   Tertiary                    NA                       NA   −
  Theca cells                                                
   Secondary                   −                        −    −
   Tertiary                    NA                       NA   −
   Endothelial cells           −                        −    −
  Follicular fluid             −                        −    +++

−, no staining detected; +, weak; ++, moderate; +++, strong; NA, not available.

Expression Changes of NLRP3 Inflammasomes in the Ovary During the Follicular Development Induced by PMSG {#S3.SS2}
--------------------------------------------------------------------------------------------------------

For confirming the above findings, the expressions of NLRP3 and ASC were further examined by Western blotting ([Figure 3](#F3){ref-type="fig"}) and the results also suggested NLRP3 and ASC mainly expressed in the ovaries after PMSG-52 h treatment, indicating the activation of NLRP3 inflammasomes this time. Therefore, the expressions of cleaved-caspase-1 were detected ([Figure 4](#F4){ref-type="fig"}) and then found a significant decrease of pro-caspase-1 expression and a dramatic increase of cleaved-caspase-1 expression in the ovaries after PMSG-52 h treatment ([Figure 4](#F4){ref-type="fig"}), implying NLRP3 inflammasomes may be involved in the following ovulation induced by MPSG.

![NLRP3 and ASC protein expressions in the ovary during the follicular development induced by PMSG. **(A)** Representative ECL gel images of Western blot analyses depicting the NLRP3 and ASC protein levels. **(B)** Summarized intensities of NLRP3 and ASC blots normalized to the control. Each value represents the mean ± SE. One-way analysis of variance (ANOVA) was used to analyze the data, followed by a Tukey's multiple range test. *n* = 6. ^\#^*P* \< 0.05, vs. PMSH-0 h; ^&^*P* \< 0.05, vs. PMSH-24 h.](fcell-07-00256-g003){#F3}

![Pro-caspase-1 and cleaved-caspase-1 protein expressions in the ovary during the follicular development induced by PMSG. **(A)** Representative ECL gel images of Western blot analyses depicting the pro-caspase-1 and cleaved-caspase-1 protein levels. **(B)** Summarized intensities of pro-caspase-1 and cleaved-caspase-1 blots normalized to the control. Each value represents the mean ± SE. One-way analysis of variance (ANOVA) was used to analyze the data, followed by a Tukey's multiple range test. *n* = 6. ^\#^*P* \< 0.05, vs. PMSH-0 h; ^&^*P* \< 0.05, vs. PMSH-24 h.](fcell-07-00256-g004){#F4}

Expression and Localization of IL-1β in the Ovary During the Follicular Development Induced by PMSG {#S3.SS3}
---------------------------------------------------------------------------------------------------

Given IL-1β production resulted from the activation of NLRP3 inflammasomes, the present study examined the expression ([Figure 5](#F5){ref-type="fig"} and [Table 3](#T3){ref-type="table"}) and localization ([Figure 5](#F5){ref-type="fig"}) of IL-1β in the ovary during the follicular development induced by PMSG and the results further demonstrated IL-1β mainly expressed in the outside of intrafollicular fluid ([Figure 5](#F5){ref-type="fig"}) and significantly increased ([Figure 6](#F6){ref-type="fig"}) in the ovaries with PMSG-52 h treatment, which were similar with the expression pattern of NLRP3 and ASC proteins.

![IL-1β Immunohistochemistry in the ovary during the follicular development induced by PMSG Ovarian sections were immunostained for IL-1β and counterstained with hematoxylin. The IL-1β immunohistochemical signals appear brown, and the background counterstaining appears blue. Negative control remained unstained, lacking primary antibody instead of serum. GC, granulosa cell; Oo, oocyte; bar = 100 μm.](fcell-07-00256-g005){#F5}

###### 

Relative abundances of IL-1β in the ovary during follicular development induced by PMSG.

  **Follicular development**   **Staining intensity**         
  ---------------------------- ------------------------ ----- -----
  Oocyte                                                      
   Primordial                  −                        NA    NA
   Primary                     \+                       \+    \+
   Secondary                   ++                       +++   +++
   Tertiary                    NA                       NA    +++
  Granulosa cells                                             
   Primordial                  −                        NA    NA
   Primary                     −                        −     −
   Secondary                   −                        −     −
   Tertiary                    NA                       NA    −
  Theca cells                                                 
   Secondary                   \+                       \+    \+
   Tertiary                    NA                       NA    ++
   Endothelial cells           −                        −     −
  Follicular fluid             −                        −     +++

−, no staining detected; +, weak; ++, moderate; +++, strong; NA, not available.

![IL-1β protein expressions in the ovary during the follicular development induced by PMSG. **(A)** Representative ECL gel images of Western blot analyses depicting the IL-1β protein levels. **(B)** Summarized intensities of IL-1β blots normalized to the control. Each value represents the mean ± SE. One-way analysis of variance (ANOVA) was used to analyze the data, followed by a Tukey's multiple range test. *n* = 6. ^\#^*P* \< 0.05, vs. PMSH-0 h; ^&^*P* \< 0.05, vs. PMSH-24 h.](fcell-07-00256-g006){#F6}

Activity Changes of Caspase-1 in the Ovary During the Follicular Development Induced by PMSG {#S3.SS4}
--------------------------------------------------------------------------------------------

Furthermore, the present study also examined caspase-1 activity ([Figure 7A](#F7){ref-type="fig"}) and IL-1b production ([Figure 7B](#F7){ref-type="fig"}) through ELISA kits and further found a significant increase of caspase-1 activity ([Figure 7A](#F7){ref-type="fig"}) and a dramatic increase of IL-1β production ([Figure 7B](#F7){ref-type="fig"}), suggesting NLRP3 inflammasomes were activated and involved in the following ovulation induced by MPSG.

![Examination of caspase-1 activity and IL-1β production in the ovary during the follicular development induced by PMSG. **(A)** The data for caspase-1 activity in the ovaries from each group normalized to the control (PMSG-0 h). **(B)** The data for IL-1β production in the ovaries from each group normalized to the control (PMSG-0 h). Each value represents the mean ± SE. One-way analysis of variance (ANOVA) was used to analyze the data, followed by a Tukey's multiple range test. *n* = 6. ^\#^*P* \< 0.05, vs. PMSH-0 h; ^&^*P* \< 0.05, vs. PMSH-24 h.](fcell-07-00256-g007){#F7}

Expression Changes of Ovulation-Related Genes in the Ovary During the Follicular Development Induced by PMSG {#S3.SS5}
------------------------------------------------------------------------------------------------------------

Finally, the expressions of ovulation-related genes, HIF-1α ([Figure 8A](#F8){ref-type="fig"}) and ET-1 ([Figure 8B](#F8){ref-type="fig"}), were examined through real time PCR and found their expressions also increased significantly in the ovaries with PMSG-52 h treatment ([Figure 8](#F8){ref-type="fig"}), suggesting the activation of NLRP3 inflammasomes may take participate in the ovulatory process with the detailed mechanism to be further clarified. Together, the present study not only summarized the expression changes of NLRP3 inflammasomes during the follicular development ([Figure 9A](#F9){ref-type="fig"}), but also put forward the possible role of NLRP3 inflammasomes during the following ovulation ([Figure 9B](#F9){ref-type="fig"}).

![Expression changes of HIF-1α and ET-1 mRNA in the ovaries during the follicular development induced by PMSG. **(A)** The relative mRNA levels of HIF-1α by real-time PCR analysis. **(B)** The relative mRNA levels of ET-1 by real-time PCR analysis. Each value represents the mean ± SE. One-way analysis of variance (ANOVA) was used to analyze the data, followed by a Tukey's multiple range test. *n* = 6. ^\#^*P* \< 0.05, vs. PMSH-0 h; ^&^*P* \< 0.05, vs. PMSH-24 h.](fcell-07-00256-g008){#F8}

![Expression pattern and possible role of NLRP3 inflammasomes in the ovaries during the follicular development induced by PMSG. **(A)** Expression pattern of NLRP3 inflammasomes in the ovarian follicles during the follicular development induced by PMSG. **(B)** Possible role of NLRP3 inflammasomes in the PMSG-treated ovaries during the follicular development and the following ovulation.](fcell-07-00256-g009){#F9}

Discussion {#S4}
==========

The present study mainly examined that expression of NLRP3 inflammasomes during the follicular development induced by PMSG, clearly demonstrating that the activation of NLRP3 inflammasomes may take participate in the following process of ovulation, which will help to further clarify the ovulatory mechanism in mammals.

Pregnant mare serum gonadotropin is mainly similar to FSH and widely used for superovulation ([@B21]; [@B31]; [@B24]; [@B16]), the present study therefore, utilized PMSG to trigger the follicular development and the following ovulation for examining the expression changed of NLRP3 inflammasomes during the follicular development and clarifying the possible role of NLRP3 inflammasomes during the following ovulation. It's well-known that inflammation is involved in the ovulatory process ([@B12]; [@B10]; [@B25]; [@B29]), but the detailed mechanism regulating the crosstalk between the inflammatory and ovulatory processes still remains unclear. Therefore, the contribution of the inflammatory processes to the ovulation in mammalian ovaries recently attracted more and more attention ([@B12]; [@B10]; [@B25]; [@B29]). [@B10] Found the parallel of the ovulatory and inflammatory processes with many common features, ovarian granulosa cells executed an inflammatory reaction during the ovulation ([@B25]), obesity reduced ovarian oocyte quality with inflammation ([@B29]), inflammatory markers in the follicular fluid were correlated with body mass index ([@B12]), and so on. Given the important role of NLRP3 inflammasomes in the inflammatory responses ([@B39]; [@B41]), the present study examined expressions of NLRP3 inflammasomes during the follicular development induced by PMSG and found NLRP3 and ASC expressions significantly increased after PMSG-52 h treatment, which were consistent with the dramatic increases of caspase-1 activity and IL-1β production, suggesting NLRP3 inflammasomes were activated before the ovulation and involved in the following ovulation. This findings of NLRP3 inflammasome activation could be a new mechanism regulating the ovulatory process in mammals.

Notably, the present study also found that expression and activation of NLRP3 inflammasomes in ovarian oocytes were prior to those in the follicular fluid, suggesting which was regulated by oocyte quality or maturation. Recent investigations have also demonstrated the coordination of ovulation with oocyte maturation and the decisive effects of oocytes during the ovulatory process ([@B27]). Interestingly, the present results showed that expressions and activation of NLRP3 inflammasomes in the outside of intrafollicular fluid after PMSG-52 h treatment, suggesting the regional responses in the ovulatory follicles ([@B10]), which contributed to the apical stretching and thinning ([@B10]). Previous studies have indicated ETs facilitated follicular rupture at the apex ([@B17]; [@B8]; [@B5]) and HIF-1α regulated ovulation-related gene expression ([@B40]; [@B34]; [@B32]) during the ovulatory process. Therefore, the present study further examined the expressions of HIF-1α and ET-1 and found their expression patterns were similar with NLRP inflammasomes, demonstrating the possible contribution of NLRP inflammasomes to the ovulation.

Furthermore, the correlation between non-steroidal anti-inflammatory drug use and reversible infertility in women indicated the ovulatory processes with inflammatory responses ([@B3]; [@B23]; [@B10]), further implying the activation of NLRP3 inflammasomes may play an important role in the regulation of ovarian ovulation in mammals. Although the present findings is very interesting and helpful for further understanding the molecular regulation of the ovulatory process, some more detailed investigations need to be performed in the near future for finally clarifying the relationship between the activation of NLRP3 inflammasomes and the ovulation of mammalian ovaries.

In summarize, the present study firstly demonstrated the expression and activation of NLRP3 inflammasomes during the follicular development induced by PMSG, which may contribute to the following ovulation. Furthermore, enhanced understanding of the contribution and regulation of NLRP3 inflammasomes during ovarian ovulation will be helpful to treat anovulatory infertility, like luteinized unruptured follicle syndrome and polycystic ovary syndrome.
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